Tech tools are creating positive change in Cardiac MRI Software Market
By Christine Book
November 09, 2022
AI-powered Software Solutions Enhance Cardiac Diagnostics
Interventional cardiologists know well the phrase “change is the only constant.” This is especially relevant as…
Read More
Artificial intelligence-powered alternative data is driving novel and disruptive market research opportunities at a staggering clip amid category growth forecasts, prompting industries of every size and sort to capitalize on this strategy that’s ever evolving and innovating 
By Merilee Kern, MBA
November 09, 2022
AI-Powered Alternative Data Driving Extreme Market Research Disruption
Numerous indicators make clear that the next five years will usher in extreme transformation for a multitude of…
Read More
New genomic therapies for cardiovascular disease are reaching the clinical trial stage, according to moderators of a session presented at the American Heart Association Annual Scientific Session (AHA2022).
November 08, 2022
Progress Reported on Clinical Trials of Genomic Profiling for Cardiovascular Disease at AHA 2022
November 8, 2022 — Genomic-based therapies for cardiovascular disease are emerging fast in research, and could soon be…
Read More
Robert J. Mentz, M.D., Associate Professor of Medicine, Chief, Heart Failure Section, Associate Program Director, Duke Cardiology Fellowship, Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina, image copyright Robert J. Mentz
November 08, 2022
TRANSFORM-HF Trial Found No Difference in Effectiveness Between 2 Common Loop Diuretics
November 8, 2022 — After hospital discharge for heart failure, people treated with either loop diuretic medication…
Read More
Julian D. Gillmore, M.D., Ph.D., Professor, University College London Centre for Amyloidosis, United Kingdom, image copyright University College London Centre for Amyloidosis
November 08, 2022
Novel Gene-Editing Therapy Shows Promise For Patients With Transthyretin Amyloid Cardiomyopathy
November 8, 2022 — A single IV infusion of NTLA-2001, a novel CRISPR/Cas9-based gene editing therapy, significantly…
Read More
Clinical studies presented at the American Heart Association 2022 Scientific Sessions event demonstrate compelling diagnostic and health economic value of the Zio suite of products across a range of clinical applications
November 08, 2022
Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22
November 8, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions…
Read More
Cardio StillShot enables 6x higher temporal resolution compared to conventional image reconstruction methods by detecting and correcting motion in the heart
November 08, 2022
Fujifilm Introduces Scenaria View Focus Edition CT Scanner with Cardio StillShot, a new Cardiac Motion Correction Feature
November 8, 2022 — Fujifilm Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging…
Read More
Using coronary computed tomography angiography (CCTA) with HeartFlow’s FFRCT Analysis to evaluate suspected coronary artery disease (CAD) offers more accurate non-invasive diagnosis, fewer unnecessary tests, and higher confidence in identifying patients needing treatment
November 07, 2022
Late-Breaking Data Demonstrate AHA/ACC Guideline-Directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing
November 7, 2022 — HeartFlow, Inc., the leader in revolutionizing precision heartcare, today announced new trial…
Read More
A new analysis of iRhythm’s mSToPS trial, presented at the American Heart Association, reveals that Zio XT provided high value from a health economic perspective
November 07, 2022
New Research Confirms that Zio by iRhythm Provides High Value From a Health Economic Perspective
November 7, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions…
Read More
Petr Ostadal, M.D., Ph.D., Professor of Medicine, Department of Cardiology, Na Homolce Hospital, Czech Republic. Image copyright Na Homolce Hospital
November 07, 2022
Early Use of ECMO devices Did Not Improve Outcomes in People With Cardiogenic Shock
November 7, 2022 — The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO…
Read More
Discover the key features of cardiovascular structured reporting that drive adoption, including automated data flow, EHR integration, and customizability.
November 07, 2022
Benefits of Cardiovascular Structured Reporting
Discover the key features of cardiovascular structured reporting that drive adoption, including automated data flow,…
Read More
New guidance covers recommendations for surgery, imaging, family screening, and the importance of a multidisciplinary team
November 05, 2022
AHA and ACC Issue New Guideline on Aortic Disease
Nov. 4, 2022 — The American College of Cardiology and the American Heart Association have published a new guideline on…
Read More
Study Advances Efforts to Launch CARDIALYTICS Suite of Analytic Tools
November 05, 2022
CathVision Announces Initiation of Clinical Study Evaluating Signal Complexity Algorithm
Nov. 4, 2022 — CathVision, a medical technology company developing innovative electrophysiology solutions to enhance…
Read More
The American Society of Nuclear Cardiology has issued an alert about possible supply disruptions
November 05, 2022
Alert: Mo-99/Tc-99m Supply Disruptions Possible
Nov. 4, 2022 — On October 28, the Nuclear Medicine Europe Emergency Response Team issued a statement about mechanical…
Read More
Late-breaking clinical presentations at VIVA show IN.PACT Admiral drug-coated PTA balloon catheter outperforms bare metal stents; maintains performance in real-world setting
November 03, 2022
Clinical Studies Show Medtronic Drug Coated Balloon Outperforms Bare Metal Stents; Maintains Performance in Real World
November 3, 2022 — Medtronic, a global leader in medical technology, today announced the results of two clinical…
Read More
A mouse heart with immune infiltrates leading to ICI-myocarditis. Image courtesy of UCSF
November 03, 2022
Study Sheds Light on the Reasons Behind Sex Differences in Myocarditis
November 3, 2022 — In the past several years, myocarditis has been of public interest because of cases associated with…
Read More
Fig. 1. Selective reduction of succinyl-CoA among the TCA cycle metabolites in cardiac muscle during chronic HF. Relative levels of the TCA cycle metabolites in cardiac muscles isolated from myocardial infarction (MI) mice, compared with those from sham mice, 28 d after surgery. Each data point in the dot plot represents one individual mouse sample (n = 38 for both groups for all metabolites, except for succinyl-CoA in which n = 18 for both groups). Concentrations of succinyl-CoA in these samples were 2.2–5
November 03, 2022
How Heart Failure Disrupts the Cell's Powerhouse
November 3, 2022 — Chronic heart failure causes the cell’s powerhouses to dysfunction, in part due to overconsumption…
Read More
About one-fifth of implants of left ventricular-assist devices have the complication of right heart failure. Abbott Laboratories (adapted)
November 02, 2022
Study Sifts Potential Factors of Device-Implant Complication
November 2, 2022 — For decades, left ventricular-assist devices (LVADs) have extended the lives of people whose hearts…
Read More
After mRNA vaccination, adults under 40 have a slightly greater chance of developing myocarditis or pericarditis, yet the vaccine’s benefits outweigh the risks, according to the American Journal of Preventive Medicine
November 02, 2022
Getting to the Heart of COVID-19 Vaccination and its Cardiovascular Risks
November 2, 2022 —  A comprehensive review and meta-analysis of published research confirm that young adults (40 years…
Read More
2D model showing how the pluripotent stem cells react to human relevant doses of cadmium over 8 days. From the control in the first panel, to the last panel, researchers can see how the differentiation to cardiomyocytes is inhibited with different doses of cadmium.
November 02, 2022
New 3D Model Shows How Cadmium Exposure May Affect Heart Development
November 2, 2022 —  Researchers have developed a three-dimensional model that shows how exposure to cadmium might lead…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now